Med BioGene Appoints Geneticist Michael R. Hayden as Director
Med BioGene Inc is pleased to announce that Michael R. Hayden, MD, PhD, FRCPC, has joined the company’s Board of Directors.
Read MoreSearch Results for: lung cancer
Clarient Acquires Applied Genomics
Posted by Clinical Lab Products | Dec 23, 2009 | Cancer, Company News |
Clarient Inc has announced that it has acquired privately held, Huntsville, Ala-based Applied Genomics Inc (AGI) in an all-stock merger valued at up to $17.6 million.
Read MoreTransgenomic Launches SURVEYOR Scan K-RAS Mutation Detection Kit
Posted by Clinical Lab Products | Dec 9, 2009 | Cancer, Miscellaneous |
Transgenomic announced the launch of its SURVEYOR Scan K-RAS kit, the first in a family of mutation detection kits the company plans to offer featuring its proprietary SURVEYOR Nuclease and WAVE HS DHPLC platform.
Read MoreNew technology Defines New Prostate-specific Antigen Zero
Posted by Clinical Lab Products | Oct 21, 2009 | Cancer, Miscellaneous |
A team of Northwestern University researchers, using an extremely sensitive tool based on nanotechnology, has detected previously undetectable levels of prostate-specific antigen (PSA) in patients who have undergone radical prostatectomy.
Read MoreGen-Probe Begins U.S. Clinical Study of PROGENSA PCA3 Assay
Posted by Clinical Lab Products | Aug 28, 2009 | Cancer, Miscellaneous |
Gen-Probe Incorporated (NASDAQ: GPRO) announced that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy.
Read More